iopromide has been researched along with Pancreatic Neoplasms in 24 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with pancreatic cancer continue to have a poor prognosis, with a 5-y survival rate of less than 5%." | 2.73 | Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer. ( Bhure, U; Clavien, PA; Hany, TF; Heinrich, S; Pestalozzi, BC; Soyka, J; Strobel, K; Veit-Haibach, P, 2008) |
| "Isoattenuating pancreatic cancers were more commonly observed among the 20-mm or smaller tumors (16 of 59, 27%) than among the 21-30-mm tumors (12 of 93, 13%) (P = ." | 1.37 | Small (≤ 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. ( Baek, JH; Cho, JY; Choi, BI; Han, JK; Kim, JE; Kim, SH; Kim, SJ; Lee, JM; Lee, JY; Lee, KB; Moon, SK; Yoon, SH, 2011) |
| "Helical CT allowed detection of pancreatic cancer in 74 of 76 cases (97%)." | 1.30 | Pancreatic cancer: value of dual-phase helical CT in assessing resectability. ( Diehl, SJ; Georgi, M; Lachmann, R; Lehmann, KJ; Sadick, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 15 (62.50) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Muenzfeld, H | 1 |
| Mahjoub, S | 1 |
| Roehle, R | 1 |
| Pelzer, U | 1 |
| Bahra, M | 1 |
| Boening, G | 1 |
| Hamm, B | 2 |
| Geisel, D | 1 |
| Auer, TA | 1 |
| Bian, Y | 1 |
| Jiang, H | 1 |
| Ma, C | 1 |
| Cao, K | 1 |
| Fang, X | 1 |
| Li, J | 2 |
| Wang, L | 1 |
| Zheng, J | 1 |
| Lu, J | 1 |
| Ren, S | 1 |
| Zhao, R | 1 |
| Zhang, J | 1 |
| Guo, K | 1 |
| Gu, X | 1 |
| Duan, S | 1 |
| Wang, Z | 1 |
| Chen, R | 1 |
| Zaboriene, I | 1 |
| Zviniene, K | 1 |
| Lukosevicius, S | 1 |
| Ignatavicius, P | 1 |
| Barauskas, G | 1 |
| Kim, C | 1 |
| Byun, JH | 4 |
| Hong, SM | 3 |
| An, S | 1 |
| Kim, JH | 4 |
| Lee, SS | 4 |
| Kim, HJ | 3 |
| Li, P | 1 |
| Deng, W | 1 |
| Xue, H | 2 |
| Xu, K | 1 |
| Zhu, L | 2 |
| Sun, Z | 1 |
| Jin, Z | 2 |
| Foti, G | 1 |
| Boninsegna, L | 1 |
| Falconi, M | 1 |
| Mucelli, RP | 1 |
| Kim, DW | 1 |
| Kim, KW | 1 |
| Song, KB | 2 |
| Seo, N | 1 |
| Kim, SC | 1 |
| Han, DJ | 1 |
| Lee, MG | 2 |
| Shi, X | 1 |
| Wu, H | 1 |
| Chen, G | 1 |
| Sun, H | 1 |
| He, Y | 1 |
| Liang, Z | 1 |
| Zhang, Z | 1 |
| Strobel, K | 1 |
| Heinrich, S | 1 |
| Bhure, U | 1 |
| Soyka, J | 1 |
| Veit-Haibach, P | 1 |
| Pestalozzi, BC | 1 |
| Clavien, PA | 1 |
| Hany, TF | 1 |
| Park, HS | 1 |
| Lee, JM | 4 |
| Choi, HK | 1 |
| Hong, SH | 1 |
| Han, JK | 4 |
| Choi, BI | 4 |
| Macari, M | 1 |
| Spieler, B | 1 |
| Kim, D | 1 |
| Graser, A | 1 |
| Megibow, AJ | 1 |
| Babb, J | 1 |
| Chandarana, H | 1 |
| Davenport, MS | 1 |
| Caoili, EM | 1 |
| Cohan, RH | 1 |
| Hoff, CN | 1 |
| Ellis, JH | 1 |
| Baek, JH | 2 |
| Kim, SH | 4 |
| Kim, SJ | 2 |
| Lee, JY | 2 |
| Park, SH | 1 |
| Yu, ES | 1 |
| Kim, MH | 1 |
| Kim, J | 1 |
| Hwang, HJ | 1 |
| Hwang, JY | 1 |
| Grieser, C | 1 |
| Steffen, IG | 1 |
| Grajewski, L | 1 |
| Stelter, L | 1 |
| Streitparth, F | 1 |
| Schnapauff, D | 1 |
| Glanemann, M | 1 |
| Langrehr, J | 1 |
| Andreou, A | 1 |
| Neuhaus, P | 1 |
| Hänninen, EL | 1 |
| Denecke, T | 1 |
| Yoon, SH | 1 |
| Cho, JY | 1 |
| Lee, KB | 1 |
| Kim, JE | 1 |
| Moon, SK | 2 |
| Böhm, I | 1 |
| Pfützner, W | 1 |
| Klose, KJ | 1 |
| Chu, AJ | 1 |
| Lee, YJ | 1 |
| Schueller, G | 1 |
| Schima, W | 1 |
| Schueller-Weidekamm, C | 1 |
| Weber, M | 1 |
| Stift, A | 1 |
| Gnant, M | 1 |
| Prokesch, R | 1 |
| Klauss, M | 1 |
| Mohr, A | 1 |
| von Tengg-Kobligk, H | 1 |
| Friess, H | 1 |
| Singer, R | 1 |
| Seidensticker, P | 1 |
| Kauczor, HU | 1 |
| Richter, GM | 1 |
| Kauffmann, GW | 1 |
| Grenacher, L | 1 |
| Diehl, SJ | 1 |
| Lehmann, KJ | 1 |
| Sadick, M | 1 |
| Lachmann, R | 1 |
| Georgi, M | 1 |
| Bernatik, T | 1 |
| Strobel, D | 1 |
| Hahn, EG | 1 |
| Becker, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Low Dose Multi-arterial Phase CT Imaging for Improved Detection of Liver Tumors and Pancreatic Masses[NCT04813432] | 50 participants (Actual) | Observational | 2018-09-10 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for iopromide and Pancreatic Neoplasms
| Article | Year |
|---|---|
Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Iohexol; Pancreatic Neoplasms; Patient Selection; Po | 2008 |
Multidetector CT of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast.
Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Contrast Media; Female; Humans; Iohexol; Male; Mi | 2006 |
22 other studies available for iopromide and Pancreatic Neoplasms
| Article | Year |
|---|---|
Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Clinical Pr | 2019 |
Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Cross-Sectional Studies; Female; Humans; Iohexol; Ma | 2020 |
Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Topics: Adult; Aged; Algorithms; Carcinoma, Pancreatic Ductal; Contrast Media; Diagnosis, Differential; Fema | 2020 |
Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Topics: Adult; Aged; Algorithms; Carcinoma, Pancreatic Ductal; Contrast Media; Diagnosis, Differential; Fema | 2020 |
Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Topics: Adult; Aged; Algorithms; Carcinoma, Pancreatic Ductal; Contrast Media; Diagnosis, Differential; Fema | 2020 |
Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Topics: Adult; Aged; Algorithms; Carcinoma, Pancreatic Ductal; Contrast Media; Diagnosis, Differential; Fema | 2020 |
Dynamic Perfusion Computed Tomography and Apparent Diffusion Coefficient as Potential Markers for Poorly Differentiated Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Iohexol; | 2021 |
A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis.
Topics: Contrast Media; Female; Fibrosis; Humans; Iohexol; Male; Middle Aged; Neoplasm Grading; Neuroendocri | 2017 |
Weight-adapted ultra-low-dose pancreatic perfusion CT: radiation dose, image quality, and perfusion parameters.
Topics: Aged; Body Weight; Contrast Media; Feasibility Studies; Female; Humans; Iohexol; Male; Middle Aged; | 2019 |
Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI.
Topics: Adult; Aged; Contrast Media; Female; Humans; Iohexol; Magnetic Resonance Imaging; Male; Middle Aged; | 2013 |
Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Contrast Media; Female; Humans; Iohexol; Male; Middle Aged; | 2015 |
Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance Imaging: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Carcinoma, P | 2016 |
CT Imaging Biomarkers Predict Clinical Outcomes After Pancreatic Cancer Surgery.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers; China; Contrast Media; Female; Humans; I | 2016 |
Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT.
Topics: Adult; Aged; Aged, 80 and over; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Female | 2009 |
Dual-source dual-energy MDCT of pancreatic adenocarcinoma: initial observations with data generated at 80 kVp and at simulated weighted-average 120 kVp.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Iohexol; Male; Middle Aged; | 2010 |
Pancreatic manifestations of von Hippel-Lindau disease-effect of imaging on clinical management.
Topics: Adolescent; Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; I | 2010 |
Small (
Topics: Adolescent; Adult; Aged; Analysis of Variance; Atrophy; Calcinosis; Carcinoma, Papillary; Chi-Square | 2010 |
Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations.
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Biopsy; Contrast Media; Female; Humans; Iohexol; Mag | 2010 |
Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses.
Topics: Area Under Curve; Contrast Media; Female; Humans; Image Processing, Computer-Assisted; Imaging, Thre | 2010 |
Small (≤ 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Female; Hum | 2011 |
[Individual management permits contrast media enhanced CT examination without premedication ].
Topics: Aged; Contrast Media; Drug Eruptions; Female; Humans; Intradermal Tests; Iohexol; Iopamidol; Neuroen | 2012 |
Dual-source, dual-energy multidetector CT for the evaluation of pancreatic tumours.
Topics: Adult; Aged; Contrast Media; Female; Humans; Iohexol; Male; Middle Aged; Multidetector Computed Tomo | 2012 |
A new invasion score for determining the resectability of pancreatic carcinomas with contrast-enhanced multidetector computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Iohexol; Male; Middle Aged; Neoplasm | 2008 |
Pancreatic cancer: value of dual-phase helical CT in assessing resectability.
Topics: Adenocarcinoma; Angiography; Contrast Media; Evaluation Studies as Topic; Female; Humans; Image Proc | 1998 |
Detection of liver metastases: comparison of contrast-enhanced wide-band harmonic imaging with conventional ultrasonography.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Female; Humans; Image Enhancement; Iohexol; Liver Neopla | 2001 |